Tomáš Cihlář
Cambridge Health Alliance(US)Alliance Pharmaceutical (United States)(US)Gilead Sciences (Spain)(ES)Gilead Sciences (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, HIV/AIDS Research and Interventions
Most-Cited Works
- → Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV(2020)1,802 cited
- → Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses(2017)1,619 cited
- → Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys(2016)1,579 cited
- → Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease(2018)1,503 cited
- → Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection(2020)936 cited
- → Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2(2020)737 cited